Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Fish welfare and anaesthetic use
Zebrafish

Scientists assess the humaneness of drugs

The welfare standards of millions of fish used for scientific research could be improved thanks to a new study, which examined the levels of stress caused by different anaesthetics.

Carrying out the research, scientists from the University of Bristol's School of Veterinary Sciences and AstraZeneca Brixham Environmental Laboratory investigated whether the right drugs are currently being used.

Fish are used by scientists all over the world to study the developmental origins of health and disease. As zebrafish embryos are transparent and develop outside of the body, they allow simple study of the developing embryo, and are therefore the most commonly used laboratory fish.

The research team aimed to find out if the level of stress caused by anaesthetics was inhumane by studying the swimming behaviour of fish.

The effects of nine of the most commonly used drugs were evaluated using video tracking software to measure the swimming behaviour of mixed-sex adult zebrafish.

When each anaesthetic was used at 50 per cent of its standard recommended dose, compared to clean water in a flow-through chematoxic choice chamber, the research team found that several of the drugs caused swimming behaviour associated with dislike.

Two of these anaesthetics were the among the most commonly recommended and widely used for fish - MS222 (ethyl 3-aminobenzoate methanesulphate) and benzocaine.

Researchers found that two of the agents, etomidate and 2,2,2 tribromoethanol, did not induce adverse behavioural responses. In fact, the team says that etomidate appeared to be the best suited for future, humane use.

While there have been advancements in general veterinary anaesthetics used for mammals, scientists say fish have fallen behind in this research. It is hoped that this work will help to address the balance.

Dr Jo Murrell, senior lecturer at the university, said: "With tens of millions of fish used in science around the world, it is very important that the anaesthetics used to do this are the most humane available and do not themselves cause a stress response." 

Related News
Tropical fish study offers insights into MS
Study shows fish do not feel pain

 

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.